Clinical Trial Update: Clinical Analysis of HIPEC for T4 Colorectal Cancer After Surgery [Phase 3]

View source ↗

Summary

An update on a Phase 3 clinical analysis evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for T4 colorectal cancer after surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Colorectal Neoplasms | Phase 3 | Status: UNKNOWN